MicroRNAs in vascular aging and atherosclerosis

Ageing Research Reviews

Volumn 17, Issue , 2014, Pages 68-78

  Menghini, Rossella ^a   Stöhr, Robert ^a   Federici, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Atherosclerosis; Endothelial dysfunction; Endothelial sencescence; Inflammation

Indexed keywords

LIPOPROTEIN; MICRORNA;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOPHAGY; B LYMPHOCYTE; BLOOD VESSEL; CELL ACTIVATION; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHRONIC INFLAMMATION; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL INFLAMMATION; ENDOTHELIAL SENESCENCE; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; LIPID TRANSPORT; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLIC DISORDER; MONONUCLEAR CELL; NONHUMAN; PATHOPHYSIOLOGY; POLARIZATION; REVIEW; SENESCENCE; T LYMPHOCYTE; VASCULAR AGING; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; AGING; ANIMAL; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADAPTIVE IMMUNITY; AGING; ANIMALS; ATHEROSCLEROSIS; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNITY, INNATE; MICRORNAS; PLAQUE, ATHEROSCLEROTIC;

EID: 84906791735     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.03.005     Document Type: Review

References (124)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Andersson J., Libby P., Hansson G.K. Adaptive immunity and atherosclerosis. Clin. Immunol. 2010, 134:33-46.
3. Androulidaki A., Iliopoulos D., Arranz A., Doxaki C., Schworer S., Zacharioudaki V., Margioris A.N., Tsichlis P.N., Tsatsanis C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009, 31:220-231.
4. Basso K., Sumazin P., Morozov P., Schneider C., Maute R.L., Kitagawa Y., Mandelbaum J., Haddad J., Chen C.Z., Califano A., Dalla-Favera R. Identification of the human mature B cell miRNome. Immunity 2009, 30:744-752.
5. Bazzoni F., Rossato M., Fabbri M., Gaudiosi D., Mirolo M., Mori L., Tamassia N., Mantovani A., Cassatella M.A., Locati M. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5282-5287.
6. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 2005, 37:766-770.
7. Boldin M.P., Taganov K.D., Rao D.S., Yang L., Zhao J.L., Kalwani M., Garcia-Flores Y., Luong M., Devrekanli A., Xu J., Sun G., Tay J., Linsley P.S., Baltimore D. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 2011, 208:1189-1201.
8. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., Burchfield J., Fox H., Doebele C., Ohtani K., Chavakis E., Potente M., Tjwa M., Urbich C., Zeiher A.M., Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
9. Boon R.A., Seeger T., Heydt S., Fischer A., Hergenreider E., Horrevoets A.J., Vinciguerra M., Rosenthal N., Sciacca S., Pilato M., van Heijningen P., Essers J., Brandes R.P., Zeiher A.M., Dimmeler S. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ. Res. 2011, 109:1115-1119.
10. Brandes R.P., Fleming I., Busse R. Endothelial aging. Cardiovasc. Res. 2005, 66:286-294.
11. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89:331-340.
12. Bruunsgaard H., Skinhoj P., Pedersen A.N., Schroll M., Pedersen B.K. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin. Exp. Immunol. 2000, 121:255-260.
13. Busch M., Zernecke A. microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis. J. Mol. Med. 2012, 90:877-885.
14. Campisi J., Andersen J.K., Kapahi P., Melov S. Cellular senescence: a link between cancer and age-related degenerative disease?. Semin. Cancer Biol. 2011, 21:354-359.
15. Ceolotto G., Papparella I., Bortoluzzi A., Strapazzon G., Ragazzo F., Bratti P., Fabricio A.S., Squarcina E., Gion M., Palatini P., Semplicini A. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am. J. Hypertens. 2011, 24:241-246.
16. Ceppi M., Pereira P.M., Dunand-Sauthier I., Barras E., Reith W., Santos M.A., Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2735-2740.
17. Chang J., Nicolas E., Marks D., Sander C., Lerro A., Buendia M.A., Xu C., Mason W.S., Moloshok T., Bort R., Zaret K.S., Taylor J.M. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004, 1:106-113.
18. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
19. Chen K.C., Wang Y.S., Hu C.Y., Chang W.C., Liao Y.C., Dai C.Y., Juo S.H. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2011, 25:1718-1728.
20. Chen T., Huang Z., Wang L., Wang Y., Wu F., Meng S., Wang C. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc. Res. 2009, 83:131-139.
21. Chen T., Li Z., Jing T., Zhu W., Ge J., Zheng X., Pan X., Yan H., Zhu J. MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells. FEBS Lett. 2011, 585:567-573.
22. Chen T., Yan H., Li Z., Jing T., Zhu W., Ge J., Zheng X., Pan X., Yan H., Zhu J. MicroRNA-155 regulates lipid uptake, adhesion/chemokine marker secretion and SCG2 expression in oxLDL-stimulated dendritic cells/macrophages. Int. J. Cardiol. 2011, 147:446-447.
23. Cheng Y., Kuang W., Hao Y., Zhang D., Lei M., Du L., Jiao H., Zhang X., Wang F. Downregulation of miR-27a* and miR-532-5p and upregulation of miR-146a and miR-155 in LPS-induced RAW264.7 macrophage cells. Inflammation 2012, 35:1308-1313.
24. Cobb B.S., Nesterova T.B., Thompson E., Hertweck A., O'Connor E., Godwin J., Wilson C.B., Brockdorff N., Fisher A.G., Smale S.T., Merkenschlager M. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 2005, 201:1367-1373.
25. Cuervo A.M. Autophagy and aging: keeping that old broom working. Trends Genet.: TIG 2008, 24:604-612.
26. Curtale G., Citarella F., Carissimi C., Goldoni M., Carucci N., Fulci V., Franceschini D., Meloni F., Barnaba V., Macino G. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010, 115:265-273.
27. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 2001, 107:1255-1262.
28. Dimmeler S., Nicotera P. MicroRNAs in age-related diseases. EMBO Mol. Med. 2013, 5:180-190.
29. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:9363-9367.
30. Elmen J., Lindow M., Schutz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjarn M., Hansen H.F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E.M., Kauppinen S. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.
31. Fang Y., Shi C., Manduchi E., Civelek M., Davies P.F. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13450-13455.
32. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 2009, 1792:497-505.
33. Fenton M., Barker S., Kurz D.J., Erusalimsky J.D. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler. Thromb. Vasc. Biol. 2001, 21:220-226.
34. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C.W., Roxe T., Muller-Ardogan M., Bonauer A., Zeiher A.M., Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 2010, 107:677-684.
35. Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.F., Wythe J.D., Ivey K.N., Bruneau B.G., Stainier D.Y., Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 2008, 15:272-284.
36. Fontana L., Pelosi E., Greco P., Racanicchi S., Testa U., Liuzzi F., Croce C.M., Brunetti E., Grignani F., Peschle C. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat. Cell Biol. 2007, 9:775-787.
37. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflammaging: an evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
38. Gareus R., Kotsaki E., Xanthoulea S., van der Made I., Gijbels M.J., Kardakaris R., Polykratis A., Kollias G., de Winther M.P., Pasparakis M. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 2008, 8:372-383.
39. George S.J., Zaltsman A.B., Newby A.C. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. Cardiovasc. Res. 1997, 33:447-459.
40. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell 2001, 104:503-516.
41. Graff J.W., Dickson A.M., Clay G., McCaffrey A.P., Wilson M.E. Identifying functional microRNAs in macrophages with polarized phenotypes. J. Biol. Chem. 2012, 287:21816-21825.
42. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 2006, 6:508-519.
43. Harris T.A., Yamakuchi M., Ferlito M., Mendell J.T., Lowenstein C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1516-1521.
44. Hashimi S.T., Fulcher J.A., Chang M.H., Gov L., Wang S., Lee B. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 2009, 114:404-414.
45. Hoekstra M., van der Lans C.A., Halvorsen B., Gullestad L., Kuiper J., Aukrust P., van Berkel T.J., Biessen E.A. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem. Biophys. Res. Commun. 2010, 394:792-797.
46. Hou J., Wang P., Lin L., Liu X., Ma F., An H., Wang Z., Cao X. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 2009, 183:2150-2158.
47. Huang R.S., Hu G.Q., Lin B., Lin Z.Y., Sun C.C. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J. Invest. Med.: Off. Publ. Am. Fed. Clin. Res. 2010, 58:961-967.
48. Icli B., Wara A.K., Moslehi J., Sun X., Plovie E., Cahill M., Marchini J.F., Schissler A., Padera R.F., Shi J., Cheng H.W., Raghuram S., Arany Z., Liao R., Croce K., Macrae C., Feinberg M.W. MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling. Circ. Res. 2013, 113:1231-1241.
49. Iliopoulos D., Drosatos K., Hiyama Y., Goldberg I.J., Zannis V.I. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J. Lipid Res. 2010, 51:1513-1523.
50. Ito T., Yagi S., Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 2010, 398:735-740.
51. Jansen F., Yang X., Nickenig G., Werner N., Vasa-Nicotera M. Role, function and therapeutic potential of microRNAs in vascular aging. Curr. Vasc. Pharmacol. 2013.
52. Jeon T.I., Osborne T.F. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab.: TEM 2012, 23:65-72.
53. Jiang M., Xiang Y., Wang D., Gao J., Liu D., Liu Y., Liu S., Zheng D. Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell 2012, 11:29-40.
54. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., Brummelkamp T.R., Fleming M.D., Camargo F.D. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
55. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
56. Kurowska-Stolarska M., Alivernini S., Ballantine L.E., Asquith D.L., Millar N.L., Gilchrist D.S., Reilly J., Ierna M., Fraser A.R., Stolarski B., McSharry C., Hueber A.J., Baxter D., Hunter J., Gay S., Liew F.Y., McInnes I.B. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11193-11198.
57. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol.: CB 2002, 12:735-739.
58. Lahoute C., Herbin O., Mallat Z., Tedgui A. Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat. Rev. Cardiol. 2011, 8:348-358.
59. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., Kauppinen S., Orum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
60. Li T., Morgan M.J., Choksi S., Zhang Y., Kim Y.S., Liu Z.G. MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat. Immunol. 2010, 11:799-805.
61. Liu G., Friggeri A., Yang Y., Park Y.J., Tsuruta Y., Abraham E. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15819-15824.
62. Liu X., Cheng Y., Yang J., Xu L., Zhang C. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J. Mol. Cell. Cardiol. 2012, 52:245-255.
63. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res. 2009, 104:476-487.
64. Lu C., Huang X., Zhang X., Roensch K., Cao Q., Nakayama K.I., Blazar B.R., Zeng Y., Zhou X. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 2011, 117:4293-4303.
65. Lu L.F., Thai T.H., Calado D.P., Chaudhry A., Kubo M., Tanaka K., Loeb G.B., Lee H., Yoshimura A., Rajewsky K., Rudensky A.Y. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009, 30:80-91.
66. Ma F., Xu S., Liu X., Zhang Q., Xu X., Liu M., Hua M., Li N., Yao H., Cao X. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat. Immunol. 2011, 12:861-869.
67. Ma X., Ma C., Zheng X. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?. Heart Lung Circ. 2013, 22:811-818.
68. Madrigal-Matute J., Rotllan N., Aranda J.F., Fernandez-Hernando C. MicroRNAs and atherosclerosis. Curr. Atheroscler. Rep. 2013, 15:322.
69. Marquart T.J., Allen R.M., Ory D.S., Baldan A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12228-12232.
70. Martin M.M., Lee E.J., Buckenberger J.A., Schmittgen T.D., Elton T.S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem. 2006, 281:18277-18284.
71. Martinez-Nunez R.T., Louafi F., Sanchez-Elsner T. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J. Biol. Chem. 2011, 286:1786-1794.
72. McCoy C.E., Sheedy F.J., Qualls J.E., Doyle S.L., Quinn S.R., Murray P.J., O'Neill L.A. IL-10 inhibits miR-155 induction by toll-like receptors. J. Biol. Chem. 2010, 285:20492-20498.
73. Menghini R., Casagrande V., Cardellini M., Martelli E., Terrinoni A., Amati F., Vasa-Nicotera M., Ippoliti A., Novelli G., Melino G., Lauro R., Federici M. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009, 120:1524-1532.
74. Menghini R., Casagrande V., Federici M. MicroRNAs in endothelial senescence and atherosclerosis. J. Cardiovasc. Transl. Res. 2013, 6:924-930.
75. Menghini R., Casagrande V., Marino A., Marchetti V., Cardellini M., Stoehr R., Rizza S., Martelli E., Greco S., Mauriello A., Ippoliti A., Martelli F., Lauro R., Federici M. MiR-216a: a link between endothelial dysfunction and autophagy. Cell Death Dis. 2014, 5:e1029.
76. Merkerova M., Belickova M., Bruchova H. Differential expression of microRNAs in hematopoietic cell lineages. Eur. J. Haematol. 2008, 81:304-310.
77. Miles E.A., Rees D., Banerjee T., Cazzola R., Lewis S., Wood R., Oates R., Tallant A., Cestaro B., Yaqoob P., Wahle K.W., Calder P.C. Age-related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis 2008, 196:298-305.
78. Minamino T., Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 2007, 100:15-26.
79. Moore K.J., Rayner K.J., Suarez Y., Fernandez-Hernando C. The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu. Rev. Nutr. 2011, 31:49-63.
80. Moreno P.R., Bernardi V.H., Lopez-Cuellar J., Newell J.B., McMellon C., Gold H.K., Palacios I.F., Fuster V., Fallon J.T. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996, 94:3098-3102.
81. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
82. Muljo S.A., Ansel K.M., Kanellopoulou C., Livingston D.M., Rao A., Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 2005, 202:261-269.
83. Nahid M.A., Pauley K.M., Satoh M., Chan E.K. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J. Biol. Chem. 2009, 284:34590-34599.
84. Najafi-Shoushtari S.H., Kristo F., Li Y., Shioda T., Cohen D.E., Gerszten R.E., Naar A.M. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328:1566-1569.
85. Noren Hooten N., Abdelmohsen K., Gorospe M., Ejiogu N., Zonderman A.B., Evans M.K. microRNA expression patterns reveal differential expression of target genes with age. PLoS ONE 2010, 5:e10724.
86. O'Connell R.M., Chaudhuri A.A., Rao D.S., Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7113-7118.
87. O'Sullivan J.F., Martin K., Caplice N.M. Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: a finger in the dam. J. Am. Coll. Cardiol. 2011, 57:383-389.
88. Olivieri F., Rippo M.R., Prattichizzo F., Babini L., Graciotti L., Recchioni R., Procopio A.D. Toll like receptor signaling in inflammaging: microRNA as new players. Immun. Ageing 2013, 10:11.
89. Olivieri F., Rippo M.R., Procopio A.D., Fazioli F. Circulating inflamma-miRs in aging and age-related diseases. Front. Genet. 2013, 4:121.
90. Ota H., Eto M., Kano M.R., Ogawa S., Iijima K., Akishita M., Ouchi Y. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1634-1639.
91. Paulson K.E., Zhu S.N., Chen M., Nurmohamed S., Jongstra-Bilen J., Cybulsky M.I. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ. Res. 2010, 106:383-390.
92. Plowden J., Renshaw-Hoelscher M., Engleman C., Katz J., Sambhara S. Innate immunity in aging: impact on macrophage function. Aging Cell 2004, 3:161-167.
93. Ponnuswamy P., Van Vre E.A., Mallat Z., Tedgui A. Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells. Vasc. Pharmacol. 2012, 56:193-203.
94. Raitoharju E., Lyytikainen L.P., Levula M., Oksala N., Mennander A., Tarkka M., Klopp N., Illig T., Kahonen M., Karhunen P.J., Laaksonen R., Lehtimaki T. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere vascular study. Atherosclerosis 2011, 219:211-217.
95. Rao D.S., O'Connell R.M., Chaudhuri A.A., Garcia-Flores Y., Geiger T.L., Baltimore D. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 2010, 33:48-59.
96. Rayner K.J., Sheedy F.J., Esau C.C., Hussain F.N., Temel R.E., Parathath S., van Gils J.M., Rayner A.J., Chang A.N., Suarez Y., Fernandez-Hernando C., Fisher E.A., Moore K.J. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 2011, 121:2921-2931.
97. Rayner K.J., Suarez Y., Davalos A., Parathath S., Fitzgerald M.L., Tamehiro N., Fisher E.A., Moore K.J., Fernandez-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
98. Rippe C., Blimline M., Magerko K.A., Lawson B.R., LaRocca T.J., Donato A.J., Seals D.R. MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation. Exp. Gerontol. 2012, 47:45-51.
99. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., Vetrie D., Okkenhaug K., Enright A.J., Dougan G., Turner M., Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
100. Rosa A., Ballarino M., Sorrentino A., Sthandier O., De Angelis F.G., Marchioni M., Masella B., Guarini A., Fatica A., Peschle C., Bozzoni I. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19849-19854.
101. Rossi R.L., Rossetti G., Wenandy L., Curti S., Ripamonti A., Bonnal R.J., Birolo R.S., Moro M., Crosti M.C., Gruarin P., Maglie S., Marabita F., Mascheroni D., Parente V., Comelli M., Trabucchi E., De Francesco R., Geginat J., Abrignani S., Pagani M. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat. Immunol. 2011, 12:796-803.
102. Ruggiero T., Trabucchi M., De Santa F., Zupo S., Harfe B.D., McManus M.T., Rosenfeld M.G., Briata P., Gherzi R. LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2009, 23:2898-2908.
103. Sene A., Khan A.A., Cox D., Nakamura R.E., Santeford A., Kim B.M., Sidhu R., Onken M.D., Harbour J.W., Hagbi-Levi S., Chowers I., Edwards P.A., Baldan A., Parks J.S., Ory D.S., Apte R.S. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 2013, 17:549-561.
104. Sun X., Icli B., Wara A.K., Belkin N., He S., Kobzik L., Hunninghake G.M., Vera M.P., Registry M., Blackwell T.S., Baron R.M., Feinberg M.W. MicroRNA-181b regulates NF-kappaB-mediated vascular inflammation. J. Clin. Invest. 2012, 122:1973-1990.
105. Swirski F.K., Nahrendorf M., Libby P. The ins and outs of inflammatory cells in atheromata. Cell Metab. 2012, 15:135-136.
106. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12481-12486.
107. Tall A.R., Yvan-Charvet L., Terasaka N., Pagler T., Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab. 2008, 7:365-375.
108. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., Schmidt-Supprian M., Rajewsky N., Yancopoulos G., Rao A., Rajewsky K. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608.
109. Ugalde A.P., Ramsay A.J., de la Rosa J., Varela I., Marino G., Cadinanos J., Lu J., Freije J.M., Lopez-Otin C. Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J. 2011, 30:2219-2232.
110. Vanhoutte P.M., Shimokawa H., Tang E.H., Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. 2009, 196:193-222.
111. Vasile E., Tomita Y., Brown L.F., Kocher O., Dvorak H.F. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2001, 15:458-466.
112. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., Newman J., Bronson R.T., Crowley D., Stone J.R., Jaenisch R., Sharp P.A., Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132:875-886.
113. Wei Y., Nazari-Jahantigh M., Chan L., Zhu M., Heyll K., Corbalan-Campos J., Hartmann P., Thiemann A., Weber C., Schober A. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis. Circulation 2013, 127:1609-1619.
114. Wei Y., Nazari-Jahantigh M., Neth P., Weber C., Schober A. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?. Arterioscler. Thromb. Vasc. Biol. 2013, 33:449-454.
115. Wei Y., Schober A., Weber C. Pathogenic arterial remodeling: the good and bad of microRNAs. Am. J. Physiol. Heart Circ. Phys. 2013, 304:H1050-H1059.
116. Xiao C., Calado D.P., Galler G., Thai T.H., Patterson H.C., Wang J., Rajewsky N., Bender T.P., Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159.
117. Xiao C., Srinivasan L., Calado D.P., Patterson H.C., Zhang B., Wang J., Henderson J.M., Kutok J.L., Rajewsky K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9:405-414.
118. Yang K., He Y.S., Wang X.Q., Lu L., Chen Q.J., Liu J., Sun Z., Shen W.F. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett. 2011, 585:854-860.
119. Zempo N., Kenagy R.D., Au Y.P., Bendeck M., Clowes M.M., Reidy M.A., Clowes A.W. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J. Vasc. Surg. 1994, 20:209-217.
120. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., Hristov M., Koppel T., Jahantigh M.N., Lutgens E., Wang S., Olson E.N., Schober A., Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2009, 2:ra81.
121. Zhang Y., Zhang M., Zhong M., Suo Q., Lv K. Expression profiles of miRNAs in polarized macrophages. Int. J. Mol. Med. 2013, 31:797-802.
122. Zhao T., Li J., Chen A.F. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E110-E116.
123. Zhou B., Wang S., Mayr C., Bartel D.P., Lodish H.F. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:7080-7085.
124. Zhu N., Zhang D., Chen S., Liu X., Lin L., Huang X., Guo Z., Liu J., Wang Y., Yuan W., Qin Y. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 2011, 215:286-293.